Concepedia

Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment

Victoria C. Yan, Florian L. Müller

ACS Medicinal Chemistry Letters · 2020 · 171 citations · 22 references

DOIFull text

Open access

Concepts

Abstract

efficacy in the veterinary setting, we contend that GS-441524 is superior to remdesivir for Covid-19 treatment.

References

22

Remdesivir for the Treatment of Covid-19 — Final Report

John H. Beigel, Kay M Tomashek, Lori E. Dodd et al. · New England Journal of Medicine · 2020 · 7.7K citations · Full text

, , +15

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Yeming Wang, Dingyu Zhang, Guanhua Du et al. · The Lancet · 2020 · 3.7K citations · Full text

, , +4

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

Dominic Wichmann, Jan‐Peter Sperhake, Marc Lütgehetmann et al. · Annals of Internal Medicine · 2020 · 2.4K citations · Full text

, , +15

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

Timothy P. Sheahan, Amy Sims, Rachel L. Graham et al. · Science Translational Medicine · 2017 · 1.6K citations · Full text

, , +14

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

Travis K. Warren, Robert Jordan, Michael K. Lo et al. · Nature · 2016 · 1.6K citations · Full text

, , +17